Medicare Part B Demo Program Will Miss March 7 Start-Up Goal
This article was originally published in The Pink Sheet Daily
The Medicare law set a 90-day deadline to begin the $500 mil. program to expand Medicare coverage of alternatives to physician-administered drugs. The law also offered confusing advice on how CMS should allocate the money.
You may also be interested in...
Caremark/AdvancePCS will administer the drug benefit for the oral chemotherapy demonstration, while South Carolina Blues subsidiary Trailblazer will handle enrollment, eligibility and education. CMS expects the demo to be enrolling patients by mid-July.
FDA’s draft guidance on systemic lupus erythematosus drug development lists four possible claims that the agency “may be willing to approve”: reduction in disease activity; organ-specific lupus treatment; complete clinical response/remission; and reduction in flares.